In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice

G. Norata, G. Canti, L. Ricci, A. Nicolin, E. Trezzi, A. L. Catapano

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

A tumour line inoculated in mice showed high affinity binding for lipoproteins in vitro. Studies in vivo demonstrated that the assimilation of human low density lipoprotein (LDL) by the tumour was very high. Both receptor and non-receptor mediated catabolism of the lipoprotein by the tumour increased as compared to other tissues known to be sites of lipoprotein catabolism (liver, spleen etc.). These findings suggest that lipoproteins may be useful markers for tumours as well as carriers for cytotoxic drugs to target tissues in vivo.

Original languageEnglish
Pages (from-to)203-208
Number of pages6
JournalCancer Letters
Volume25
Issue number2
DOIs
Publication statusPublished - 1984

Fingerprint

Fibrosarcoma
LDL Lipoproteins
Lipoproteins
Neoplasms
Drug Carriers
Tumor Biomarkers
Spleen
Liver

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Biology

Cite this

In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. / Norata, G.; Canti, G.; Ricci, L.; Nicolin, A.; Trezzi, E.; Catapano, A. L.

In: Cancer Letters, Vol. 25, No. 2, 1984, p. 203-208.

Research output: Contribution to journalArticle

Norata, G. ; Canti, G. ; Ricci, L. ; Nicolin, A. ; Trezzi, E. ; Catapano, A. L. / In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. In: Cancer Letters. 1984 ; Vol. 25, No. 2. pp. 203-208.
@article{06612a48c162469ea72d7d531d841c3f,
title = "In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice",
abstract = "A tumour line inoculated in mice showed high affinity binding for lipoproteins in vitro. Studies in vivo demonstrated that the assimilation of human low density lipoprotein (LDL) by the tumour was very high. Both receptor and non-receptor mediated catabolism of the lipoprotein by the tumour increased as compared to other tissues known to be sites of lipoprotein catabolism (liver, spleen etc.). These findings suggest that lipoproteins may be useful markers for tumours as well as carriers for cytotoxic drugs to target tissues in vivo.",
author = "G. Norata and G. Canti and L. Ricci and A. Nicolin and E. Trezzi and Catapano, {A. L.}",
year = "1984",
doi = "10.1016/S0304-3835(84)80046-4",
language = "English",
volume = "25",
pages = "203--208",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice

AU - Norata, G.

AU - Canti, G.

AU - Ricci, L.

AU - Nicolin, A.

AU - Trezzi, E.

AU - Catapano, A. L.

PY - 1984

Y1 - 1984

N2 - A tumour line inoculated in mice showed high affinity binding for lipoproteins in vitro. Studies in vivo demonstrated that the assimilation of human low density lipoprotein (LDL) by the tumour was very high. Both receptor and non-receptor mediated catabolism of the lipoprotein by the tumour increased as compared to other tissues known to be sites of lipoprotein catabolism (liver, spleen etc.). These findings suggest that lipoproteins may be useful markers for tumours as well as carriers for cytotoxic drugs to target tissues in vivo.

AB - A tumour line inoculated in mice showed high affinity binding for lipoproteins in vitro. Studies in vivo demonstrated that the assimilation of human low density lipoprotein (LDL) by the tumour was very high. Both receptor and non-receptor mediated catabolism of the lipoprotein by the tumour increased as compared to other tissues known to be sites of lipoprotein catabolism (liver, spleen etc.). These findings suggest that lipoproteins may be useful markers for tumours as well as carriers for cytotoxic drugs to target tissues in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0021685106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021685106&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(84)80046-4

DO - 10.1016/S0304-3835(84)80046-4

M3 - Article

VL - 25

SP - 203

EP - 208

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -